Select Issue or Sub-issues

• +Access to medicines
  • All Access to medicines
  • Equitable access
  • Funder step-in rights
  • Outbreak preparedness
  • Pandemic Products
  • Policy considerations
  • Affordable or reasonable pricing
  • Public health licenses
  • Supply/Purchase of Products
• +Annexes
  • All Annexes
  • Commercialization strategy
  • Global access plans
• +Business model
  • All Business model
  • Benefit/revenue sharing
  • Risk sharing
  • Royalties & payments
• +Consortium structure & management
  • Consortium structure & management
• +Information sharing & data safety
  • All Information sharing & data safety
  • Confidentiality
  • Data management
  • Exceptions and limitations to the confidentiality obligations
  • Information sharing
  • Material transfer
  • Technology transfer
• +IP ownership & licensing
  • All IP ownership & licensing
  • Access to results
  • Exceptions or limitations to the IP ownership rules
  • Exploitation of results
  • Ownership of background IP
  • Ownership of results
  • Protection of results
  • Sublicenses
  • Use of background IP
• +Liability
  • All Liability
  • Indemnity / indemnification
  • Insurance
  • Limitation of liability/damage
  • Representations & Warranties
• +Open sciences & open data
  • All Open sciences & open data
  • Open data
  • Open sciences
  • Publication
• +Other
  • All Other
  • Conflict of Interest
  • Dispute resolution
  • Regulatory strategy
  • Reporting
  • Survival
• +Term & termination
  • All Term & termination
  • Effect of termination
  • Term of agreement
  • Termination & withdrawal